Icosavax

Icosavax is a Washington-based biotechnology company that develops and commercializes VLP vaccines for the treatment of respiratory diseases.

Business Model:

Revenue: $2.7M

Employees: 11-50

Detailed Icosavax Information

Geographic Data

Icosavax headquarters map

Address: 1616 Eastlake Avenue E.

City: Seattle

State: WA

Zip: 98102

Country: US

Financial Info

Stage:

series b

Raised Last:

$100M

Raised Total:

$161M

Metrics

4,817,520Website Global Rank

1,782Website Monthly Traffic

Twitter Followers

Description

Icosavax is a Washington-based biotechnology company that develops and commercializes VLP vaccines for the treatment of respiratory diseases.

Contact Phone:
+12063365600

Contact Email:

Icosavax went public on 7/29/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/29/2021

IPO Valuation:
$563M

Ticker Symbol:
ICVX

IPO Price:
$15/share

Amount Raised:
$182M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
7/2021 IPO $182M
7/2021 IPO $100M
8/2019 Series A $51M Qiming Venture Partners USA
Adams Street Partners
Sanofi Ventures
NanoDimension
1/2018 Seed $4.5M
4/2021 Series B $0 Sanofi Ventures
Qiming Venture Partners USA
RA Capital Management
Viking Global Investors
Omega Funds
Open Philanthropy Project
Perceptive Advisors
Cormorant Asset Management
NanoDimension
Surveyor Capital
RA Capital Management
Adams Street Partners
Janus Henderson Investors
Sanofi Ventures
Qiming Venture Partners USA
RA Capital Management
Viking Global Investors
Omega Funds
Open Philanthropy Project
Perceptive Advisors
Cormorant Asset Management
NanoDimension
Surveyor Capital
RA Capital Management
Adams Street Partners
Janus Henderson Investors
1/2017 Pre Seed Round 1 - Sahsen Ventures
Sahsen Ventures
1/2018 Seed Round -
10/2020 Grant 1 $10M Bill &a; Melinda Gates Foundation
Bill &a; Melinda Gates Foundation
10/2019 Series A $0 Sanofi
Qiming Venture Partners USA
Adams Street Partners
NanoDimension
Sanofi Ventures
Sanofi
Qiming Venture Partners USA
Adams Street Partners
NanoDimension
Sanofi Ventures
3/2021 Series B $100M RA Capital Management
Janus Henderson Investors
Perceptive Advisors
Viking Global Investors
Surveyor Capital
Qiming Venture Partners USA
Adams Street Partners
Sanofi Ventures
ND Capital
RA Capital Management
Janus Henderson Investors
Perceptive Advisors
Viking Global Investors
Surveyor Capital
Qiming Venture Partners USA
Adams Street Partners
Sanofi Ventures
ND Capital
4/2021 Series B 12 $100M Sanofi Ventures
Qiming Venture Partners USA
RA Capital Management
Viking Global Investors
Omega Funds
Open Philanthropy Project
Perceptive Advisors
Cormorant Asset Management
NanoDimension
Surveyor Capital
RA Capital Management
Sanofi Ventures
Qiming Venture Partners USA
RA Capital Management
Viking Global Investors
Omega Funds
Open Philanthropy Project
Perceptive Advisors
Cormorant Asset Management
NanoDimension
Surveyor Capital
RA Capital Management
10/2019 Series A 5 $51M Qiming Venture Partners USA
Qiming Venture Partners USA
1/2018 Seed Round -
1/2017 Pre Seed Round 1 -
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research